A Global Comparison Between Brand-Name and Generic Drugs
Karan Chawla1, Taraneh Tofighi2, Arnav Agarwal2, Jason Thomas3, Tapas Mondal4★★ Corresponding author
- 1Honours Biology (Physiology Specialization), Faculty of Science, McMaster University, 1280 Main Street West, Hamilton, ON, Canada, L8S 4L8.
- 2Honours Bachelor of Health Sciences, Faculty of Health Sciences, McMaster University, 1280 Main Street West, Hamilton, ON, Canada, L8S 4L8.
- 3Pharmacy Services, Juravinski Cancer Center , 699 Concession Street, Hamilton, ON, Canada, L8V 5C2.
- 4Department of Pediatrics, McMaster Children’s Hospital, 1200 Main Street West, Hamilton, ON, Canada, L8N 3Z5.
CORRESPONDENCE
Tapas Mondal
Department of Pediatrics, McMaster Children’s Hospital, 1200 Main Street West, Hamilton, ON, Canada, L8N 3Z5.
Received: 02-06-2014; Accepted: 04-09-2014.
Volume 7, Issue 3 · pp. 23–28 · PUBLISHED · DOI: 10.5530/ijopp.7.3.6
ABSTRACT
While the use of cheaper bioequivalent generic drugs over brand-name drugs has been widely discussed in literature, their market pricing and subsequent use is largely shaped by government policy-making as well as consumer and corporate decision-making. Analysis of literature shows that drug development and testing costs, degree of health care privatization, and pharmaceutical reimbursement all impact the profitability of brand-name drugs within and beyond their patent period. Furthermore, jurisdiction-specific government controls and policies influence the affordability and accessibility of both drug variants. This literature review focuses on: a) analyzing the policies and expenses associated with gaining approval for brand-name and generic drugs, and their subsequent influence on drug pricing; and b) comparing and contrasting government controls and policies between Canada, the United States, European nations, and developing countries.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Chawla, K., Tofighi, T., Agarwal, A., Thomas, J., & Mondal, T. (). A Global Comparison Between Brand-Name and Generic Drugs. Indian Journal of Pharmacy Practice, 7(3), 23–28. https://doi.org/10.5530/ijopp.7.3.6
